{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:47:10Z","timestamp":1771274830816,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The c-Jun N-terminal kinase (JNK) is a key regulator of matrix metalloproteinase (MMP) and cytokine production in rheumatoid arthritis (RA) and JNK deficiency markedly protects mice in animal models of arthritis. Cytokine-induced JNK activation is strictly dependent on the mitogen-activated protein kinase kinase 7 (MKK7) in fibroblast-like synoviocytes (FLS). Therefore, we evaluated whether targeting MKK7 using anti-sense oligonucleotides (ASO) would decrease JNK activation and severity in K\/BxN serum transfer arthritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Three 2'-O-methoxyethyl chimeric ASOs for MKK7 and control ASO were injected intravenously in normal C57BL\/6 mice. PBS, control ASO or MKK7 ASO was injected from Day -8 to Day 10 in the passive K\/BxN model. Ankle histology was evaluated using a semi-quantitative scoring system. Expression of MKK7 and JNK pathways was evaluated by quantitative PCR and Western blot analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MKK7 ASO decreased MKK7 mRNA and protein levels in ankles by about 40% in normal mice within three days. There was no effect of control ASO on MKK7 expression and MKK7 ASO did not affect MKK3, MKK4 or MKK6. Mice injected with MKK7 ASO had significantly less severe arthritis compared with control ASO (<jats:italic>P<\/jats:italic>&lt; 0.01). Histologic evidence of synovial inflammation, bone erosion and cartilage damage was reduced in MKK7 ASO-treated mice (<jats:italic>P<\/jats:italic>&lt; 0.01). MKK7 deficiency decreased phospho-JNK and phospho-c-Jun in ankle extracts (<jats:italic>P<\/jats:italic>&lt; 0.05), but not phospho-MKK4. Interleukin-1beta (IL-1\u03b2), MMP3 and MMP13 gene expression in ankle joints were decreased by MKK7 ASO (<jats:italic>P<\/jats:italic>&lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MKK7 plays a critical regulatory role in the JNK pathway in a murine model of arthritis. Targeting MKK7 rather than JNK could provide site and event specificity when treating synovitis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/ar3750","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T16:27:09Z","timestamp":1331656029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Sang-il","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Berdeja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"3500_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS: Evolving concepts of rheumatoid arthritis. Nature. 2003, 423: 356-361. 10.1038\/nature01661.","journal-title":"Nature"},{"key":"3500_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/ard.2009.112201","volume":"69","author":"A Fukushima","year":"2010","unstructured":"Fukushima A, Boyle DL, Corr M, Firestein GS: Kinetic analysis of synovial signalling and gene expression in animal models of arthritis. Ann Rheum Dis. 2010, 69: 918-923. 10.1136\/ard.2009.112201.","journal-title":"Ann Rheum Dis"},{"key":"3500_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","volume":"47","author":"T Thalhamer","year":"2008","unstructured":"Thalhamer T, McGrath MA, Harnett MM: MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford). 2008, 47: 409-414.","journal-title":"Rheumatology (Oxford)"},{"key":"3500_CR4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-3565(24)35079-7","volume":"291","author":"Z Han","year":"1999","unstructured":"Han Z, Boyle DL, Aupperle KR, Bennett B, Manning AM, Firestein GS: Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther. 1999, 291: 124-130.","journal-title":"J Pharmacol Exp Ther"},{"key":"3500_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI12466","volume":"108","author":"Z Han","year":"2001","unstructured":"Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS: c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest. 2001, 108: 73-81.","journal-title":"J Clin Invest"},{"key":"3500_CR6","doi-asserted-by":"publisher","first-page":"22122","DOI":"10.1073\/pnas.1016401107","volume":"107","author":"M Guma","year":"2010","unstructured":"Guma M, Kashiwakura J, Crain B, Kawakami Y, Beutler B, Firestein GS, Kawakami T, Karin M, Corr M: JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis. Proc Natl Acad Sci USA. 2010, 107: 22122-22127. 10.1073\/pnas.1016401107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3500_CR7","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/art.30271","volume":"63","author":"M Guma","year":"2011","unstructured":"Guma M, Ronacher LM, Firestein GS, Karin M, Corr M: JNK-1 deficiency limits macrophage-mediated antigen-induced arthritis. Arthritis Rheum. 2011, 63: 1603-1612. 10.1002\/art.30271.","journal-title":"Arthritis Rheum"},{"key":"3500_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1042\/bj3520145","volume":"352","author":"Y Fleming","year":"2000","unstructured":"Fleming Y, Armstrong CG, Morrice N, Paterson A, Goedert M, Cohen P: Synergistic activation of stress-activated protein kinase 1\/c-Jun N-terminal kinase (SAPK1\/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J. 2000, 352: 145-154. 10.1042\/0264-6021:3520145.","journal-title":"Biochem J"},{"key":"3500_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1101\/gad.888501","volume":"15","author":"C Tournier","year":"2001","unstructured":"Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ: MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 2001, 15: 1419-1426. 10.1101\/gad.888501.","journal-title":"Genes Dev"},{"key":"3500_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.bbamcr.2006.10.016","volume":"1773","author":"X Wang","year":"2007","unstructured":"Wang X, Destrument A, Tournier C: Physiological roles of MKK4 and MKK7: insights from animal models. Biochim Biophys Acta. 2007, 1773: 1349-1357. 10.1016\/j.bbamcr.2006.10.016.","journal-title":"Biochim Biophys Acta"},{"key":"3500_CR11","first-page":"393","volume":"148","author":"Y Asaoka","year":"2010","unstructured":"Asaoka Y, Nishina H: Diverse physiological functions of MKK4 and MKK7 during early embryogenesis. J Biochem. 2010, 148: 393-401.","journal-title":"J Biochem"},{"key":"3500_CR12","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/art.11228","volume":"48","author":"M Sundarrajan","year":"2003","unstructured":"Sundarrajan M, Boyle DL, Chabaud-Riou M, Hammaker D, Firestein GS: Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum. 2003, 48: 2450-2460. 10.1002\/art.11228.","journal-title":"Arthritis Rheum"},{"key":"3500_CR13","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/art.21919","volume":"54","author":"T Inoue","year":"2006","unstructured":"Inoue T, Hammaker D, Boyle DL, Firestein GS: Regulation of JNK by MKK-7 in fibroblast-like synoviocytes. Arthritis Rheum. 2006, 54: 2127-2135. 10.1002\/art.21919.","journal-title":"Arthritis Rheum"},{"key":"3500_CR14","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","volume":"272","author":"BF Baker","year":"1997","unstructured":"Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM, Bennett CF: 2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem. 1997, 272: 11994-12000. 10.1074\/jbc.272.18.11994.","journal-title":"J Biol Chem"},{"key":"3500_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D: Organ-specific disease provoked by systemic autoimmunity. Cell. 1996, 87: 811-822. 10.1016\/S0092-8674(00)81989-3.","journal-title":"Cell"},{"key":"3500_CR16","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/art.24887","volume":"60","author":"CI Svensson","year":"2009","unstructured":"Svensson CI, Inoue T, Hammaker D, Fukushima A, Papa S, Franzoso G, Schett G, Corr M, Boyle DL, Firestein GS: Gadd45beta deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling. Arthritis Rheum. 2009, 60: 3229-3240. 10.1002\/art.24887.","journal-title":"Arthritis Rheum"},{"key":"3500_CR17","doi-asserted-by":"publisher","first-page":"R352","DOI":"10.1186\/ar1004","volume":"5","author":"DL Boyle","year":"2003","unstructured":"Boyle DL, Rosengren S, Bugbee W, Kavanaugh A, Firestein GS: Quantitative biomarker analysis of synovial gene expression by real-time PCR. Arthritis Res Ther. 2003, 5: R352-360. 10.1186\/ar1004.","journal-title":"Arthritis Res Ther"},{"key":"3500_CR18","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/ar2215","volume":"9","author":"DR Hammaker","year":"2007","unstructured":"Hammaker DR, Boyle DL, Inoue T, Firestein GS: Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther. 2007, 9: R57-10.1186\/ar2215.","journal-title":"Arthritis Res Ther"},{"key":"3500_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0945-053X(02)00007-0","volume":"21","author":"A Liacini","year":"2002","unstructured":"Liacini A, Sylvester J, Li WQ, Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 2002, 21: 251-262. 10.1016\/S0945-053X(02)00007-0.","journal-title":"Matrix Biol"},{"key":"3500_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","volume":"103","author":"RJ Davis","year":"2000","unstructured":"Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 2000, 103: 239-252. 10.1016\/S0092-8674(00)00116-1.","journal-title":"Cell"},{"key":"3500_CR21","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.ajpath.2011.06.019","volume":"179","author":"K Denninger","year":"2011","unstructured":"Denninger K, Rasmussen S, Larsen JM, Orskov C, Seier Poulsen S, Sorensen P, Christensen JP, Illges H, Odum N, Labuda T: JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis. Am J Pathol. 2011, 179: 1884-1893. 10.1016\/j.ajpath.2011.06.019.","journal-title":"Am J Pathol"},{"key":"3500_CR22","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1242\/jcs.00082","volume":"115","author":"JP David","year":"2002","unstructured":"David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF: JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci. 2002, 115: 4317-4325. 10.1242\/jcs.00082.","journal-title":"J Cell Sci"},{"key":"3500_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/385350a0","volume":"385","author":"H Nishina","year":"1997","unstructured":"Nishina H, Fischer KD, Radvanyi L, Shahinian A, Hakem R, Rubie EA, Bernstein A, Mak TW, Woodgett JR, Penninger JM: Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature. 1997, 385: 350-353. 10.1038\/385350a0.","journal-title":"Nature"},{"key":"3500_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0925-4773(99)00213-0","volume":"89","author":"K Sabapathy","year":"1999","unstructured":"Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF: Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev. 1999, 89: 115-124. 10.1016\/S0925-4773(99)00213-0.","journal-title":"Mech Dev"},{"key":"3500_CR25","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1093\/emboj\/16.23.7045","volume":"16","author":"T Moriguchi","year":"1997","unstructured":"Moriguchi T, Toyoshima F, Masuyama N, Hanafusa H, Gotoh Y, Nishida E: A novel SAPK\/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 1997, 16: 7045-7053. 10.1093\/emboj\/16.23.7045.","journal-title":"EMBO J"},{"key":"3500_CR26","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/art.30497","volume":"63","author":"Y Luo","year":"2011","unstructured":"Luo Y, Boyle DL, Hammaker D, Edgar M, Franzoso G, Firestein GS: Suppression of collagen-induced arthritis in growth arrest and DNA damage inducible 45beta (Gadd45beta)-deficient mice. Arthritis Rheum. 2011, 63: 2949-2955. 10.1002\/art.30497.","journal-title":"Arthritis Rheum"},{"key":"3500_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1517\/14712590902926089","volume":"9","author":"G Courties","year":"2009","unstructured":"Courties G, Presumey J, Duroux-Richard I, Jorgensen C, Apparailly F: RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin Biol Ther. 2009, 9: 535-538. 10.1517\/14712590902926089.","journal-title":"Expert Opin Biol Ther"},{"key":"3500_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1194\/jlr.M400492-JLR200","volume":"46","author":"RM Crooke","year":"2005","unstructured":"Crooke RM, Graham MJ, Lemonidis KM, Whipple CP, Koo S, Perera RJ: An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res. 2005, 46: 872-884. 10.1194\/jlr.M400492-JLR200.","journal-title":"J Lipid Res"},{"key":"3500_CR29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0022-3565(24)38831-7","volume":"296","author":"RS Geary","year":"2001","unstructured":"Geary RS, Watanabe TA, Truong L, Freier S, Lesnik EA, Sioufi NB, Sasmor H, Manoharan M, Levin AA: Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. J Pharmacol Exp Ther. 2001, 296: 890-897.","journal-title":"J Pharmacol Exp Ther"},{"key":"3500_CR30","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1017\/S1462399409001021","volume":"11","author":"PJ White","year":"2009","unstructured":"White PJ, Anastasopoulos F, Pouton CW, Boyd BJ: Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Expert Rev Mol Med. 2009, 11: e10-","journal-title":"Expert Rev Mol Med"},{"key":"3500_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nature01451","volume":"422","author":"SD Conner","year":"2003","unstructured":"Conner SD, Schmid SL: Regulated portals of entry into the cell. Nature. 2003, 422: 37-44. 10.1038\/nature01451.","journal-title":"Nature"},{"key":"3500_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3109\/10611861003734019","volume":"18","author":"L Huang","year":"2010","unstructured":"Huang L, Sullenger B, Juliano R: The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides. J Drug Target. 2010, 18: 567-574. 10.3109\/10611861003734019.","journal-title":"J Drug Target"},{"key":"3500_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1084\/jem.194.6.757","volume":"194","author":"T Sasaki","year":"2001","unstructured":"Sasaki T, Wada T, Kishimoto H, Irie-Sasaki J, Matsumoto G, Goto T, Yao Z, Wakeham A, Mak TW, Suzuki A, Cho SK, Zuniga-Pflucker JC, Oliveira-dos-Santos AJ, Katada T, Nishina H, Penninger JM: The stress kinase mitogen-activated protein kinase kinase (MKK)7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells. J Exp Med. 2001, 194: 757-768. 10.1084\/jem.194.6.757.","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"3500_CR34","doi-asserted-by":"publisher","first-page":"i77","DOI":"10.1136\/ard.2009.119479","volume":"69","author":"D Hammaker","year":"2010","unstructured":"Hammaker D, Firestein GS: \"Go upstream, young man\": lessons learned from the p38 saga. Ann Rheum Dis. 2010, 69 (Suppl 1): i77-82. 10.1136\/ard.2009.119479.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3750.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3750\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3750.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T02:09:38Z","timestamp":1742695778000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["3500"],"URL":"https:\/\/doi.org\/10.1186\/ar3750","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]},"assertion":[{"value":"14 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R38"}}